Beijing Tiantan Biological Products Corp Ltd Cash Flow Quality Index
Beijing Tiantan Biological Products Corp Ltd cash flow quality index. Beijing Tiantan Biological Products Corp Ltd (600161) has a Cash Flow Quality Index of 1.71x as of September 2025. Operating cash flow of CN¥318.80 Million exceeds net income of CN¥186.12 Million, indicating high earnings quality where cash backs reported profits. Explore 600161 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Cash flow quality index of Beijing Tiantan Biological Products Corp Ltd from 1998 to 2024. Historical Cash Flow Quality Index for Beijing Tiantan Biological Products Corp Ltd across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Beijing Tiantan Biological Products Corp net asset quality index to measure how much of total assets are equity-financed.
Beijing Tiantan Biological Products Corp Ltd Cash Flow Quality Index by Year (1998–2024)
Beijing Tiantan Biological Products Corp Ltd cash flow quality index by year from 1998 to 2024. Year-by-year earnings quality comparison for Beijing Tiantan Biological Products Corp Ltd. For the full cash flow conversion analysis, see cash flow conversion of Beijing Tiantan Biological Products Corp.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.39x | CN¥819.78 Million | CN¥2.11 Billion | ▼ -75.5% |
| 2023 | 1.59x | CN¥2.39 Billion | CN¥1.51 Billion | ▲ +69.7% |
| 2022 | 0.93x | CN¥1.13 Billion | CN¥1.20 Billion | ▲ +1.9% |
| 2021 | 0.92x | CN¥980.35 Million | CN¥1.07 Billion | ▲ +23.2% |
| 2020 | 0.74x | CN¥702.11 Million | CN¥943.08 Million | ▲ +3.6% |
| 2019 | 0.72x | CN¥642.47 Million | CN¥894.25 Million | ▼ -22.0% |
| 2018 | 0.92x | CN¥677.92 Million | CN¥735.90 Million | ▲ +425.6% |
| 2017 | 0.18x | CN¥218.39 Million | CN¥1.25 Billion | ▼ -87.6% |
| 2016 | 1.41x | CN¥428.37 Million | CN¥303.01 Million | ▼ -65.5% |
| 2015 | 4.09x | CN¥473.26 Million | CN¥115.58 Million | ▲ +93.7% |
| 2014 | 2.11x | CN¥477.95 Million | CN¥226.16 Million | ▲ +72.2% |
| 2013 | 1.23x | CN¥566.43 Million | CN¥461.48 Million | ▲ +5.1% |
| 2012 | 1.17x | CN¥432.00 Million | CN¥369.96 Million | ▼ -3.5% |
| 2011 | 1.21x | CN¥353.15 Million | CN¥291.84 Million | ▲ +46.2% |
| 2010 | 0.83x | CN¥184.85 Million | CN¥223.35 Million | ▼ -48.3% |
| 2009 | 1.60x | CN¥448.23 Million | CN¥280.18 Million | ▲ +13.0% |
| 2008 | 1.42x | CN¥276.39 Million | CN¥195.28 Million | ▲ +37.6% |
| 2007 | 1.03x | CN¥153.55 Million | CN¥149.32 Million | ▼ -30.2% |
| 2006 | 1.47x | CN¥154.36 Million | CN¥104.83 Million | ▼ -22.8% |
| 2005 | 1.91x | CN¥131.69 Million | CN¥69.00 Million | ▼ -17.6% |
| 2004 | 2.32x | CN¥110.11 Million | CN¥47.53 Million | ▲ +59.1% |
| 2003 | 1.46x | CN¥62.93 Million | CN¥43.23 Million | ▼ -37.4% |
| 2002 | 2.32x | CN¥84.38 Million | CN¥36.30 Million | ▲ +71.7% |
| 2001 | 1.35x | CN¥46.49 Million | CN¥34.35 Million | ▲ +7.3% |
| 2000 | 1.26x | CN¥47.90 Million | CN¥37.97 Million | ▲ +28.0% |
| 1999 | 0.99x | CN¥42.58 Million | CN¥43.20 Million | ▲ +39.6% |
| 1998 | 0.71x | CN¥23.71 Million | CN¥33.58 Million | — |